Novo Nordisk to Cut Ozempic and Wegovy List Prices by Up to 50 Percent in 2027
Novo Nordisk plans to slash the list prices of Ozempic and Wegovy by as much as 50 percent starting in 2027, a move that could reshape the economics of the booming GLP 1 drug market. The decision signals mounting pressure…